Koers IntelliPharmaCeutics International Inc. OTC Bulletin Board
Aandelen
CA4581733090
Farmaceutische producten
Omzet 2021 | - | Omzet 2022 | 65,73K 60,82K | Marktkapitalisatie | 2,47 mln. 2,28 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -5 mln. -4,63 mln. | Nettowinst (verlies) 2022 | -2 mln. -1,85 mln. | EV/omzet 2021 | - |
Nettoschuld 2021 | 1,15 mln. 1,06 mln. | Nettoschuld 2022 | 2,24 mln. 2,07 mln. | EV/omzet 2022 | 71,6 x |
K/w-verhouding 2021 |
-0,65
x | K/w-verhouding 2022 |
-0,85
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 98,24% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Amina Odidi
FOU | Founder | - | 01-01-98 |
Isa Odidi
CEO | Chief Executive Officer | - | 01-01-98 |
Comptroller/Controller/Auditor | - | 01-04-07 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Norman Betts
BRD | Director/Board Member | 68 | 22-01-19 |
Isa Odidi
CEO | Chief Executive Officer | - | 01-01-98 |
Amina Odidi
FOU | Founder | - | 01-01-98 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+46,03% | 754 mld. | |
+40,95% | 630 mld. | |
-5,69% | 352 mld. | |
+19,85% | 331 mld. | |
+9,20% | 298 mld. | |
+18,45% | 250 mld. | |
+11,88% | 217 mld. | |
-0,78% | 216 mld. | |
+6,38% | 164 mld. |